1-3 of 3
G di Isernia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits.

Free
P Tagliaferri, G Tortora, R Guarrasi, V Damiano, A Ruggiero, D Morelli, M Caraglia, R Bianco, G di Isernia, S Pepe, C L Arteaga, B C Langton-Webster, A R Bianco, F Ciardiello
Journal: Clinical Cancer Research
Clin Cancer Res (1996) 2 (1): 207–214.
Published: 01 January 1996
View articletitled, Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits.
Open the PDF for Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits. in another window
Journal Articles

Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells.

Free
F Ciardiello, V Damiano, C Bianco, G di Isernia, A Ruggiero, M Caraglia, P Tagliaferri, J Baselga, J Mendelsohn, A R Bianco
Journal: Clinical Cancer Research
Clin Cancer Res (1995) 1 (2): 161–167.
Published: 01 February 1995
View articletitled, Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells.
Open the PDF for Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells. in another window
Journal Articles

Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.

Free
G Tortora, F Ciardiello, V Damiano, S Pepe, C Bianco, G di Isernia, S L Davies, P North, A L Harris, I D Hickson
Journal: Clinical Cancer Research
Clin Cancer Res (1995) 1 (1): 49–56.
Published: 01 January 1995
View articletitled, Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
Open the PDF for Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. in another window